StockWatch
·
Pharmaceuticals
Board Meeting14 Oct 2026, 03:57 pm

Indoco Remedies Board Meeting on Oct 27 to Approve Q2 FY27 Results

AI Summary

Indoco Remedies Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item is the consideration and approval of the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the trading window for designated persons and their immediate relatives will remain closed until October 29, 2026, which is 48 hours after the financial results are declared.

Key Highlights

  • Board meeting scheduled for October 27, 2026.
  • To approve un-audited financial results for Q2 FY27.
  • Trading window closure extended until October 29, 2026.
  • Focus on standalone and consolidated financial performance.